Higher Sensitivity Provided by the Combination of Two Lateral Flow Immunoassay Tests for the Detection of COVID-19 Immunoglobulins
SARS-Cov-2 was identified in Wuhan, China in December 2019. The World Health Organization (WHO) declared it a pandemic in March of 2020. COVID-19 has now been reported on every continent. In the United States, the total number of confirmed reported cases of COVID-19 has exceeded 1.8 million with the...
Main Authors: | Ziad Daoud, Jesse McLeod, David L. Stockman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2020.00479/full |
Similar Items
-
Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2
by: Tove Hoffman, et al.
Published: (2021-05-01) -
Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
by: Hadeel T. Al-Jighefee, et al.
Published: (2021-02-01) -
Dataset for longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population divided by age
by: Cristina Interiano, et al.
Published: (2021-06-01) -
Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays
by: Tanja Vollmer, et al.
Published: (2016-08-01) -
GAMBARAN SEROLOGIS IgG-IgM PADA PASIEN DEMAM BERDARAH DI RSUP SANGLAH PERIODE JULI-AGUSTUS 2014
by: Putu Gde Hari Wangsa, et al.
Published: (2015-04-01)